) has been widely deployed to various types of lesions because of its promising data about the markedly reduced incidence of target lesion revascularization (TLR) with in-stent restenosis (ISR) compared with that of conventional bare metal stents (BMS). 1,2 However, several predictors for ISR and TLR after SES implantation have been reported. 3,4 In addition, although the molecular mechanism of ISR after SES implantation has been well studied, 5 the optimal method for ISR inside SES has not been fully explored. 6 Therefore, complete revascularization against ischemic coronary diseases by percutaneous coronary intervention (PCI) has not been achieved despite the upcoming era of the drug-eluting stent (DES).Ostial lesion of the right coronary artery (RCAos; which is defined as the lesion being within 3 mm of the ostia) has been a limitation of PCI because of its high ratio of restenosis after using various devices before the availability of the DES. 7-13 Furthermore, RCAos is reported to be the most powerful predictor for TLR after SES implantation, 3,4 although SES brings greater benefits for stenting to RCAos compared with BMS. 14,15 Therefore, in the present study, the angiographic and clinical outcomes after SES implantation to RCAos were retrospectively estimated. For this purpose, binary in-stent restenosis and TLR after SES implantation to de novo RCAos were compared with those of BMS and also with those of post-SES implantation to the de novo RCA proximal (RCApro; which is defined as the lesion beyond 3 mm distal from the ostia).
Methods
Study PopulationThe SES was approved in August 2004 in Japan; hence, after obtaining informed consent, the SES was routinely deployed, as described in our previous reports. 4,16,17 Briefly, the SES was routinely implanted in patients unless there was a known malignancy, pre-surgical operation, severe anemia, and the existence of various social conditions. Thus, those patients with BMS enrolled in the present study had received their implants before SES technology was approved. The quantitative coronary angiogram (QCA) data of RCAos (SES-RCAos group, n=37) and RCApro (SES-RCApro Background Although ostial lesion (defined as being within 3 mm of the ostia) of the right coronary artery (RCAos) has been a limitation of percutaneous coronary intervention after using previous various devices, the angiographic and clinical outcomes after the deployment of a sirolimus-eluting stent (SES) to RCAos have not been fully estimated. Therefore, the incidences of binary restenosis (BR; % diameter stenosis at chronic phase ≤50) and target lesion revascularization (TLR) after SES to RCAos were retrospectively compared with those after SES to RCA proximal (RCApro) and those after bare metal stents (BMS) to RCAos.
Methods and ResultsThe ratios of BR (18.9%) and TLR (13.5%) after SES to RCAos (n=37, mean follow-up interval of each group was 249 days) were significantly decreased compared with those of BMS to RCAos (41.7%, 36.1%, p<0.01, respectively) (n=36, 194 days), but were significantly in...